TriSalus Life Sciences, Inc. (TLSI) on GreekSoup https://greeksoup.ai/stocks/us/tlsi/ Every dated entry in the public record on TriSalus Life Sciences, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 TriSalus Life Sciences, Inc.: short interest 3,444,897 shares at the 15 October 2026 settlement, 20.11 days to coverhttps://greeksoup.ai/stocks/us/tlsi/short-interest/us:TLSI:short-interest:2026-10-15:36a11bb14cThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: Cox Bryan F. (Chief of Research) sold 296 shares at $4.39 on 5 October 2026, $1,299https://greeksoup.ai/stocks/us/tlsi/insiders/us:TLSI:insider:2026-10-07:b3eda703f3Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: Marshak Richard (Chief Commercial Officer) sold 325 shares at $4.39 on 5 October 2026, $1,427https://greeksoup.ai/stocks/us/tlsi/insiders/us:TLSI:insider:2026-10-07:3e11122968Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: Stevens Jennifer (Chief Regulatory Officer) sold 316 shares at $4.39 on 5 October 2026, $1,387https://greeksoup.ai/stocks/us/tlsi/insiders/us:TLSI:insider:2026-10-07:bc6c3f9c60Wed, 07 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: short interest 3,346,635 shares at the 30 September 2026 settlement, 4.41 days to coverhttps://greeksoup.ai/stocks/us/tlsi/short-interest/us:TLSI:short-interest:2026-09-30:478f55ba1aWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/tlsi/filings/us:TLSI:filing:2026-09-22:436b07659eTue, 22 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: short interest 3,345,269 shares at the 15 September 2026 settlement, 28.81 days to coverhttps://greeksoup.ai/stocks/us/tlsi/short-interest/us:TLSI:short-interest:2026-09-15:0771d90874Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: short interest 3,692,615 shares at the 31 August 2026 settlement, 35.88 days to coverhttps://greeksoup.ai/stocks/us/tlsi/short-interest/us:TLSI:short-interest:2026-08-31:7f3e411c4bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc.: short interest 3,790,922 shares at the 14 August 2026 settlement, 14.00 days to coverhttps://greeksoup.ai/stocks/us/tlsi/short-interest/us:TLSI:short-interest:2026-08-14:f122b09cecFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc. Q2 FY2026 results: revenue $11 million, net income -$9 millionhttps://greeksoup.ai/stocks/us/tlsi/results/fy2026-q2/us:TLSI:result:2026-08-06:7ac102c33bThu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/tlsi/filings/us:TLSI:filing:2026-08-06:a0701936deThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> TriSalus Life Sciences, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/tlsi/filings/us:TLSI:filing:2026-08-06:4a08318c45Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>